A chiral tridentate phosphine ligand and its preparation method and application
By developing chiral tridentate phosphine ligand based on ferrocene backbone to form metal complexes with cheap metal cobalt for asymmetric hydrogenation reaction of ketones, poor reactive activity and enantioselectivity in the prior art are solved. Problem, high reactivity and good stereoselectivity catalytic effects are achieved.
Patent Information
- Application Number
- CN202210151020.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-02-14
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2042-02-14
AI Technical Summary
Existing chiral tridentate phosphine ligands are poor in the asymmetric hydrogenation reaction of ketones, especially those of C2 symmetric chiral SPO tridentate phosphine ligands and cheap metal cobalt based on ferrocene backbone The catalyst performs poorly in the asymmetric hydrogenation reaction of ketones.
Develop a chiral tridentate phosphine ligand based on the ferrocene framework to form a metal complex with inexpensive metal cobalt for asymmetric hydrogenation reaction of ketones, prepared by mixing chiral tridentate phosphine ligand with cobalt salts Catalyst and applied to asymmetric hydrogenation reactions.
The reactivity and enantioselectivity of the asymmetric hydrogenation reaction of ketones were significantly improved, and the catalyst Co-L1 showed high reactivity and good stereoselectivity in the asymmetric hydrogenation reaction of biaryl ketones.
Smart Images

Figure CN115043885B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of asymmetric catalysis, and in particular to a chiral tridentate phosphine ligand and a preparation method and application thereof. Background Art
[0002] Secondary phosphine oxides (SPO) are stable molecules that exist in equilibrium in two tautomeric forms: pentavalent phosphine oxides and trivalent phosphonic acids. The phosphorus atom or oxygen atom of SPO can coordinate with the metal M. Compared with phosphine ligands, secondary phosphine oxide compounds show stronger power supply capabilities, are easy to synthesize, and are more stable. Our research group has reported the synthesis of SPO-Wudaphos ligands, and its rhodium complex showed excellent enantioselectivity in the asymmetric hydrogenation of α-methylene-γ-keto acids. In addition, our research group has reported non-chiral C2-symmetrical SPO tridentate phosphine ligands, and applied its ruthenium complex to the reduction of carbonyl groups. There are currently no reports of C2-symmetrical chiral SPO tridentate phosphine ligands based on the ferrocene skeleton. In addition, the catalysts formed by chiral tridentate ligands and cheap metal cobalt in current reports do not show good reactivity and enantioselectivity in the asymmetric hydrogenation of ketones. Therefore, developing new chiral SPO tridentate phosphine ligands and making them into cheap metal complexes for application in asymmetric hydrogenation reactions to improve their reaction activity and enantioselectivity is a technical problem that urgently needs to be solved. Summary of the invention
[0003] In view of this, the technical problem to be solved by the present invention is to provide a chiral tridentate phosphine ligand and a preparation method and application thereof. The chiral tridentate phosphine ligand provided by the present invention forms a metal complex with cheap metal cobalt and is applied to the asymmetric hydrogenation of ketones, which not only optimizes the reaction activity of cheap metal cobalt in the asymmetric hydrogenation reaction of ketones, but also improves the enantioselectivity.
[0004] The present invention provides a chiral tridentate phosphine ligand having a structure of formula (I),
[0005]
[0006] Here, R is a C6-C30 aryl group or a C6-C30 aryl group having a substituent.
[0007] Preferably, the substituent in the C6-C30 aryl group containing a substituent is a C1-C6 alkyl group or a halogen;
[0008] The number of substituents on the aryl group is 1, 2 or 3.
[0009] Preferably, the substituent is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, n-hexyl, fluorine, chlorine, bromine or iodine.
[0010] Preferably, R is phenyl, biphenyl, naphthyl, anthracenyl, phenanthryl, 3,5-dimethylphenyl, 3,5-diethylphenyl or 3,5-dipropylphenyl.
[0011] The present invention also provides a method for preparing a chiral tridentate phosphine ligand having a structure of formula (I), comprising:
[0012] 1) reacting a compound of formula (I-1) with HPR2 to obtain a compound of formula (I-2),
[0013]
[0014] Wherein, R is a C6-C30 aryl group or a C6-C30 aryl group containing a substituent;
[0015] 2) Converting the compound of formula (I-2) into the compound of formula (I).
[0016] The present invention also provides a catalyst having a structure of formula (II),
[0017]
[0018] Here, R is a C6-C30 aryl group or a C6-C30 aryl group having a substituent.
[0019] The present invention also provides a method for preparing a catalyst having a structure of formula (II), which is obtained by mixing and reacting the chiral tridentate phosphine ligand described in the present application with a cobalt salt.
[0020] Preferably, the cobalt salt is cobalt chloride.
[0021] The present invention also provides an asymmetric catalytic reaction, wherein the catalyst of the reaction is the catalyst of the structure of formula (II) described in the present application,
[0022]
[0023] Preferably, the asymmetric catalytic reaction is an asymmetric hydrogenation reaction.
[0024] Compared with the prior art, the present invention provides a chiral tridentate phosphine ligand and a preparation method and application thereof. The present invention constructs a chiral tridentate phosphine ligand based on a ferrocene skeleton as a ligand and further prepares a metal complex with cheap metal cobalt. The metal complex is applied to asymmetric catalytic reactions, especially to asymmetric hydrogenation of ketones. Experimental results show that not only the hydrogenation reaction has high reaction activity but also good stereoselectivity. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is the crystal structure of the catalyst Co-L1 obtained in Example. DETAILED DESCRIPTION
[0026] The present invention provides a chiral tridentate phosphine ligand having a structure of formula (I),
[0027]
[0028] Here, R is a C6-C30 aryl group or a C6-C30 aryl group having a substituent.
[0029] In the present invention, the substituent in the C6-C30 aryl group containing a substituent is a C1-C6 alkyl group or a halogen; more preferably, the substituent is a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, an n-hexyl group, fluorine, chlorine, bromine or iodine. The number of substituents on the aryl group is preferably 1, 2 or 3.
[0030] More specifically, R is phenyl, biphenyl, naphthyl, anthracenyl, phenanthryl, 3,5-dimethylphenyl, 3,5-diethylphenyl or 3,5-dipropylphenyl.
[0031] It should be pointed out that R2 in this structure refers to two Rs connected to P, and R2 in the following structures has the same meaning.
[0032] The present invention also provides a method for preparing a chiral tridentate phosphine ligand having a structure of formula (I), comprising:
[0033] 1) reacting a compound of formula (I-1) with HPR2 to obtain a compound of formula (I-2),
[0034]
[0035] Wherein, R is a C6-C30 aromatic group or a C6-C30 aromatic group containing a substituent; wherein the preferred range of R is the same as that of R in the aforementioned ligand, and Me is a methyl group.
[0036] The compound of formula (I-2) is converted into the compound of formula (I).
[0037] According to the present invention, the compound of formula (I-1) is first reacted with HPR2 to obtain a compound of formula (I-2), wherein the reaction auxiliary agent is preferably glacial acetic acid, and the reaction temperature is preferably 120-130°C.
[0038] According to the present invention, the present invention also converts the compound of formula (I-2) into the compound of formula (I). Specifically, the present invention first reacts the compound of formula (I-2) with n-butyl lithium and methyl tert-butyl ether at -30°C to -50°C, and then adds diethyl dichlorophosphine to react to obtain the compound of formula (I). More preferably, the compound of formula (I-2) reacts with n-butyl lithium and methyl tert-butyl ether at -40°C. More specifically, the preparation process of the compound of formula (I) is as follows:
[0039]
[0040] Among them, HPR2 is an aromatic phosphine, AcOH is glacial acetic acid, n-BuLi is n-butyl lithium, MTBE is methyl tert-butyl ether, Ph is phenyl, and 3,5-dimethyl-Ph is 3,5-dimethylphenyl.
[0041] The present invention also provides a catalyst having a structure of formula (II),
[0042]
[0043] Wherein, R is a C6-C30 aryl group or a C6-C30 aryl group containing a substituent. The preferred range of R is the same as the definition of R in the aforementioned ligand.
[0044] The present invention also provides a method for preparing a catalyst of formula (II), comprising: mixing and reacting the chiral tridentate phosphine ligand described in the present application with a cobalt salt. The cobalt salt is preferably cobalt chloride. The present invention has no special requirements for the reaction method, and any method known in the art for preparing a target product by reacting a similar ligand with a cobalt salt can be used.
[0045] More specifically, the preparation process of the catalyst of formula (II) is as follows:
[0046]
[0047] Wherein, CoCl2 is cobalt dichloride, THF is tetrahydrofuran, rt is room temperature, Ph is phenyl, and 3,5-dimethyl-Ph is 3,5-dimethylphenyl.
[0048] The present invention also provides an asymmetric catalytic reaction, wherein the catalyst of the reaction is the catalyst described in the present application. Wherein, the asymmetric catalytic reaction is preferably an asymmetric hydrogenation reaction, and more preferably an asymmetric hydrogenation reaction of a diaryl ketone. Wherein, the diaryl ketone preferably has a structure shown in formula (III),
[0049] Wherein, the R' is a C1-C5 alkoxy group, a C1-C6 alkyl group or a halogen, preferably, the R' is a methoxy group, an ethoxy group, a propoxy group, a butoxy group, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a tert-butyl group, a n-pentyl group, an isopentyl group, a n-hexyl group, a fluorine group, a chlorine group, a bromine group or an iodine group.
[0050] The present invention provides a chiral tridentate phosphine ligand based on a ferrocene skeleton, which is coordinated with a cheap metal cobalt to obtain a metal complex, and the metal complex is applied to an asymmetric catalytic reaction, especially to the asymmetric hydrogenation of ketones. Experiments show that the hydrogenation reaction has high reaction activity and good stereoselectivity, and has good application prospects.
[0051] The following will be described clearly and completely in conjunction with the technical solutions of the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0052] Example 1
[0053] Synthesis of compound 2a:
[0054]
[0055] Under argon atmosphere, compound 1 (15mmol, 15.74g) and glacial acetic acid (10mL) were added to a 50mL reaction bottle, followed by diphenylphosphine (16.5mmol, 3.07g). The mixed system was stirred at 120°C for 2 hours, cooled to room temperature, and diluted with dichloromethane. The organic phase was washed twice with saturated sodium bicarbonate solution, washed once with water, and then dried, and the solvent was removed under reduced pressure. Finally, ethanol was added for recrystallization, and filtered to obtain a yellow-brown solid 2a. (5.86g, yield = 74%)
[0056] 1 H NMR (400MHz, CDCl3) δ7.64–7.51(m,2H),7.47–7.35(m,3H),7.25–7.16(m,1H),7.18–7.09(m,2H),7.03–6.93(m,2H),4.36(q ,J=2.4,1.3Hz,1H),4.23(t,1H),4.14(s,4H),4.07–4.01(m,1H),3.36(qd,J=7.0,4.4Hz,1H),1.50(dd,J=13.0,7.0Hz,3H). 31 P NMR (162 MHz, CDCl3) δ 8.21.
[0057] Example 2
[0058] Synthesis of compound L1:
[0059]
[0060] Under argon, compound 2a (4mmol, 2.10g) and (20mL) were added to a 50mL reaction bottle in sequence. At -40°C, n-butyl lithium solution (2.17mol / L n-hexane solution, 4.8mmol, 2.20mL) was added dropwise to the reaction mixture. After stirring at -40°C for 1 hour, diethyl dichlorophosphine (2.0mmol, 290μL) was added dropwise and stirring was continued for 1 hour. After the reaction solution was warmed to room temperature, stirring was continued for 3 hours. Then 1mol / L hydrochloric acid solution (5mL) was added to quench, and ethyl acetate was added to extract three times. After the organic phase was dried over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and then purified by column chromatography to obtain a yellow solid L1. (900mg, yield = 53%)
[0061] 1 H NMR(600MHz, CDCl3)δ7.80(s,0.5H),7.47(t,J=7.2Hz,2H),7.40(t,J=6.8Hz,2H ),7.31(dt,J=29.5,7.3Hz,6H),7.25–7.18(m,7H),7.15(t,J=7.4Hz,1H),7.06( t,J=6.9Hz,2H),6.99(s,0.5H),4.46(s,1H),4.22(s,7H),4.12(s,7H),3.91(s, 1H), 3.65 (d, J = 7.0Hz, 2H), 1.48 (dd, J = 12.3, 6.9Hz, 3H), 1.30 (t, J = 6.6Hz, 3H).
[0062] 13C NMR (151MHz, CDCl3) δ138.0(dd,J=28.0,18.9Hz),136.1(d,J=21.1Hz),135.1,135.0,134.8(d,J=3.3Hz),134.7,132.9(d,J=16 .3Hz),131.5(d,J=14.1Hz),129.5,129.3,128.4(d,J=7.5Hz),128.3(d,J=4.0Hz),128.1(d,J=5.4Hz),128.0,127.7(d,J=7.5H z),127.3,99.1(dd,J=22.0,10.4Hz),95.2(dd,J=17.3,13.1Hz),75.1,74.4,72.6(dd,J=13.5,9.0Hz),70.3,70.1,69.9(d,J=2 6.8Hz), 69.7 (d, J = 23.4Hz), 69.2 (d, J = 11.5Hz), 67.4, 66.6, 30.0 (d, J = 16.4Hz), 28.5 (d, J = 19.5Hz), 19.2 (d, J = 14.7Hz), 17.1.
[0063] 31 P NMR (162MHz, CDCl3) δ19.85 (d, J = 10.8Hz), 11.13, 8.86 (d, J = 10.6Hz).
[0064] HRMS(ESI)m / z:[M+H] + Calcd.for C 48 H 46 Fe2OP3 + =843.1455; Found:843.1453.[α] D 24 = +86.00 (c = 0.5, CHCl3).
[0065] Example 3
[0066] Synthesis of compound L2:
[0067]
[0068] Under argon, compound 2b (2.5mmol, 1.45g) and (10mL) were added to a 50mL reaction bottle in sequence. At -40°C, n-butyl lithium solution (2.17mol / L n-hexane solution, 3.0mmol, 1.38mL) was added dropwise to the reaction mixture. After stirring at -40°C for 1 hour, diethyl dichlorophosphine (1.25mmol, 181μL) was added dropwise and stirring was continued for 1 hour. After the reaction solution was warmed to room temperature, stirring was continued for 3 hours. Then 1mol / L hydrochloric acid solution (3mL) was added to quench, and ethyl acetate was added to extract three times. After the organic phase was dried over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and then purified by column chromatography to obtain a yellow solid L2. (180mg, yield = 15%)
[0069] 1 H NMR(600MHz, CDCl3)δ7.81(s,1H),7.15(d,J=7.8Hz,2H),7.09–7.04(m,3H),7.00(d,J=7.3Hz,3H),6 .94(s,1H),6.85(s,1H),6.75(d,J=6.7Hz,2H),4.49(s,1H),4.31(s,5H),4.27(d,J=2.4Hz,1H),4.22 (s,5H),4.19(q,J=3.5,2.7Hz,3H),3.97(d,J=3.1Hz,1H),3.80(d,J=2.5Hz,1H),3.67(dq,J=7.0,4.1 Hz,1H),2.34(s,6H),2.27(s,12H),2.25(s,6H),1.56(dd,J=12.2,6.9Hz,3H),1.43(t,J=7.0Hz,3H).
[0070] 13C NMR (151MHz, CDCl3) δ137.9 (d, J = 18.5Hz), 137.6, 137.6, 137.5, 137.4 (d, J = 4.4Hz), 137.2 (d, J = 5.8Hz), 136.9 (d, J = 7.8Hz), 134.7 (d, J = 20.1Hz), 134.4(d,J=16.7Hz),133.7(d,J=21.1Hz),132.6(d,J=20.4Hz),131.0(d, J=27.2Hz),130.6(d,J=16.5Hz),129.7,129.2,129.1(d,J=9.5Hz),99.4( dd,J=21.1,10.6Hz),95.5(dd,J=17.9,12.9Hz),75.7,75.0,72.6(dd,J= 14.2,9.9Hz),70.5–70.2(m),70.2,70.0(d,J=2.0Hz),69.6–69.3(m),68. 8(d,J=11.8Hz),67.5(d,J=3.3Hz),66.7(d,J=3.8Hz),30.0(d,J=16.8Hz) ,28.3(d,J=19.4Hz),21.5,21.3(d,J=14.4Hz),19.1(d,J=14.6Hz),17.9.
[0071] 31 P NMR (243MHz, CDCl3) δ19.57 (d, J = 12.7Hz), 10.68, 10.04 (d, J = 11.9Hz).
[0072] HRMS(ESI)m / z:[M+H] + Calcd.for C 56 H 62 Fe2OP3 + =955.2707; Found:955.2697.[α] D 24 = +45.40 (c = 0.5, CHCl3).
[0073] Example 4
[0074] Synthesis of Catalyst Co-L1:
[0075]
[0076] In a glove box, weigh ligand L1 (0.5mmol, 421mg) and metal precursor cobalt dichloride (0.5mmol, 65mg) and dissolve in 10mL tetrahydrofuran, which quickly turns into a green suspension. After stirring overnight at room temperature, add 30mL dichloromethane to dissolve to obtain a green clear solution. After filtering the solution through a membrane, transfer it out of the glove box and use a vacuum pump to drain the solvent. The crude product is transferred to the glove box again and rinsed and filtered with 5mL of n-hexane. The green solid collected is the Co-L1 complex. (470mg, yield = 97%)
[0077] Its crystal structure is Figure 1 As shown, Figure 1 This is the crystal structure of the catalyst Co-L1 obtained in Example.
[0078] Example 5
[0079] Catalyst Co-L1 catalyzes the asymmetric hydrogenation of diaryl ketone 3a:
[0080]
[0081] In a glove box, weigh the diaryl ketone substrate 3a (0.1mmol), catalyst Co-L1 (0.002mmol, 2mg) and potassium tert-butoxide (0.01mmol, 1.1mg) in a 3mL hydrogenation bottle and dissolve them in 0.4mL ethanol. Transfer the hydrogenation bottle to the hydrogenation kettle, remove the glove box, connect the hydrogenation kettle to high-pressure hydrogen and replace the hydrogen three times, and fill it with 50atm hydrogen. Put the hydrogenation kettle into a preheated oil bath at 40℃ and heat and stir for 24h. Then take out the reactor from the oil bath, cool to room temperature and slowly release hydrogen in a fume hood. The crude product is purified by eluting with a petroleum ether / ethyl acetate (10 / 1) system on a small silica gel column to obtain the target product 4a as an anhydrous oil. (20.7mg, yield = 97%, 92%ee)
[0082] 1 H NMR (400MHz, CDCl3) δ7.41–7.35(m,2H),7.31(t,J=7.4Hz,2H),7.27–7.20(m,3H),6.93(t d,J=7.5,1.1Hz,1H),6.87(dd,J=8.2,1.0Hz,1H),6.04(s,1H),3.78(s,3H),2.78(s,1H). 13 C NMR (101MHz, CDCl3) δ156.76,143.31,132.00,128.75,128.19,127.87,127.18,126.58,120.83,110.79,72.25,55.44.[α] D 24= +33.15 (c = 2.0, CHCl3). UPLC conditions: Chiralpak IBU column, n-hexane / isopropanol = 90 / 10, flow rate = 0.5 mL / min, λ = 230 nm, t R =3.6min (main peak), t R =3.3min (secondary peak).
[0083] The conversion rates of Co-L1 for various substances are shown below.
[0084]
[0085] The above embodiments are only used to help understand the method and core idea of the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principles of the present invention, and these improvements and modifications also fall within the scope of protection of the claims of the present invention.
Claims
1. A chiral tridentate phosphine ligand having a structure of formula (I), in, R is a phenyl group or a phenyl group containing a substituent, wherein the substituent is a methyl group, and the number of the substituents on the phenyl group is 1 or 2.
2. The chiral tridentate phosphine ligand according to claim 1, characterized in that: The R is phenyl or 3,5-dimethylphenyl.
3. A method for preparing a chiral tridentate phosphine ligand having a structure of formula (I), comprising: 1) reacting a compound of formula (I-1) with HPR2 to obtain a compound of formula (I-2), Wherein, R is a phenyl group or a phenyl group containing a substituent, wherein the substituent is a methyl group, and the number of substituents on the phenyl group is 1 or 2; 2) converting the compound of formula (I-2) into the compound of formula (I), 4. A catalyst having a structure of formula (II), in, R is a phenyl group or a phenyl group containing a substituent, wherein the substituent is a methyl group, and the number of the substituents on the phenyl group is 1 or 2.
5. A method for preparing a catalyst having a structure of formula (II), which is obtained by mixing the chiral tridentate phosphine ligand according to claim 1 with a cobalt salt.
6. The preparation method according to claim 5, characterized in that: The cobalt salt is cobalt chloride.
7. An asymmetric catalytic reaction, wherein the catalyst of the reaction is the catalyst according to claim 4 or the catalyst prepared by the preparation method according to any one of claims 5 to 6.
8. The asymmetric catalytic reaction according to claim 7, characterized in that: The asymmetric catalytic reaction is an asymmetric hydrogenation reaction.
Citation Information
Patent Citations
Chiral ferrocene diphosphine ligands, preparation method and application thereof
CN108929345A
